These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33872855)

  • 1. Cortical morphometric correlational networks associated with cognitive deficits in first episode schizophrenia.
    Wang C; Oughourlian T; Tishler TA; Anwar F; Raymond C; Pham AD; Perschon A; Villablanca JP; Ventura J; Subotnik KL; Nuechterlein KH; Ellingson BM
    Schizophr Res; 2021 May; 231():179-188. PubMed ID: 33872855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered regional homogeneity and cognitive impairments in first-episode schizophrenia: A resting-state fMRI study.
    Huang Y; Wang W; Hei G; Yang Y; Long Y; Wang X; Xiao J; Xu X; Song X; Gao S; Shao T; Huang J; Wang Y; Zhao J; Wu R
    Asian J Psychiatr; 2022 May; 71():103055. PubMed ID: 35303593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In search of multimodal neuroimaging biomarkers of cognitive deficits in schizophrenia.
    Sui J; Pearlson GD; Du Y; Yu Q; Jones TR; Chen J; Jiang T; Bustillo J; Calhoun VD
    Biol Psychiatry; 2015 Dec; 78(11):794-804. PubMed ID: 25847180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.
    McCleery A; Ventura J; Kern RS; Subotnik KL; Gretchen-Doorly D; Green MF; Hellemann GS; Nuechterlein KH
    Schizophr Res; 2014 Aug; 157(1-3):33-9. PubMed ID: 24888526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia.
    Yang M; Gao S; Zhang X
    Transl Psychiatry; 2020 Nov; 10(1):368. PubMed ID: 33139736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of cognitive function in Chinese first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) profile of impairment.
    Zhang H; Wang Y; Hu Y; Zhu Y; Zhang T; Wang J; Ma K; Shi C; Yu X; Li C
    Gen Psychiatr; 2019; 32(3):e100043. PubMed ID: 31423473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the optimal neuropsychological test battery for schizophrenia in China?
    Shi C; Kang L; Yao S; Ma Y; Li T; Liang Y; Cheng Z; Xu Y; Shi J; Xu X; Zhang C; Franklin DR; Heaton RK; Jin H; Yu X
    Schizophr Res; 2019 Jun; 208():317-323. PubMed ID: 30718121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hyperhomocysteine and cognitive impairment in first-episode patients with schizophrenia: Moderated by brain cortical thickness.
    Lin C; Gou M; Pan S; Tong J; Zhou Y; Xie T; Yu T; Feng W; Li Y; Chen S; Tian B; Tan S; Wang Z; Luo X; Li CR; Zhang P; Huang J; Elliot Hong L; Tan Y
    Neurosci Lett; 2022 Sep; 788():136826. PubMed ID: 35944595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MATRICS consensus cognitive battery in patients with bipolar I disorder.
    Burdick KE; Goldberg TE; Cornblatt BA; Keefe RS; Gopin CB; Derosse P; Braga RJ; Malhotra AK
    Neuropsychopharmacology; 2011 Jul; 36(8):1587-92. PubMed ID: 21451499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairments in patients with first episode psychosis: The relationship between neurophysiological and neuropsychological assessments.
    Morales-Muñoz I; Jurado-Barba R; Fernández-Guinea S; Álvarez-Alonso MJ; Rodríguez-Jiménez R; Jiménez-Arriero MA; Rubio G
    J Clin Neurosci; 2017 Feb; 36():80-87. PubMed ID: 27825609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naive, first-episode patients with schizophrenia.
    Guo X; Li J; Wang J; Fan X; Hu M; Shen Y; Chen H; Zhao J
    Schizophr Res; 2014 Feb; 152(2-3):339-43. PubMed ID: 24439000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive deficits profiles in the first-episode of schizophrenia, clinical high risk of psychosis, and genetically high-risk of psychosis.
    Dong F; Mao Z; Ding Y; Wang L; Bo Q; Li F; Wang F; Wang C
    Front Psychiatry; 2023; 14():1292141. PubMed ID: 38146278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P50 inhibition deficit in patients with chronic schizophrenia: Relationship with cognitive impairment of MATRICS consensus cognitive battery.
    Xia L; Yuan L; Du XD; Wang D; Wang J; Xu H; Huo L; Tian Y; Dai Q; Wei S; Wang W; Trihn TH; Alnatour OI; Chen D; Xiu M; Wang L; Yang M; Zhang XY
    Schizophr Res; 2020 Jan; 215():105-112. PubMed ID: 31780341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery.
    Bezdicek O; Michalec J; Kališová L; Kufa T; Děchtěrenko F; Chlebovcová M; Havlík F; Green MF; Nuechterlein KH
    Schizophr Res; 2020 Apr; 218():85-92. PubMed ID: 32089475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between catechol-O-methyltransferase genetic variation and functional connectivity in patients with first-episode schizophrenia.
    Wang H; Zhang B; Zeng B; Tang Y; Zhang T; Zhao S; Li C; Wang J; Goff DC
    Schizophr Res; 2018 Sep; 199():214-220. PubMed ID: 29730044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between dorsolateral prefrontal cortex metabolic change and cognitive impairment in first-episode neuroleptic-naive schizophrenia patients.
    Huang ML; Khoh TT; Lu SJ; Pan F; Chen JK; Hu JB; Hu SH; Xu WJ; Zhou WH; Wei N; Qi HL; Shang DS; Xu Y
    Medicine (Baltimore); 2017 Jun; 96(25):e7228. PubMed ID: 28640119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia.
    Kumar S; Mulsant BH; Tsoutsoulas C; Ghazala Z; Voineskos AN; Bowie CR; Rajji TK
    Int J Geriatr Psychiatry; 2016 Oct; 31(10):1116-23. PubMed ID: 27428251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia.
    Zhang X; Yang M; Du X; Liao W; Chen D; Fan F; Xiu M; Jia Q; Ning Y; Huang X; Wu F; Soares JC; Cao B; Wang L; Chen H
    Mol Psychiatry; 2020 Dec; 25(12):3220-3230. PubMed ID: 31409883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MATRICS cognitive consensus battery (MCCB) performance in children, adolescents, and young adults.
    Nitzburg GC; Derosse P; Burdick KE; Peters BD; Gopin CB; Malhotra AK
    Schizophr Res; 2014 Jan; 152(1):223-8. PubMed ID: 24321710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.